This website offers cannabis information and is restricted to adults aged 19 years and older.

Please enter your birthdate to confirm you are at least 19 years of age.

CannTx Announces B2B Microprop and First Contract

PUSLINCH, Ontario, January 28, 2019 - CannTx Life Sciences Inc. (the “Company” or “CannTx”) is pleased to announce that it has launched Steadystem Solutions (“Steadystem) to operate as the Company’s Business-to-Business micropropagation services division.  Steadystem is focused on providing clean, synchronized genetic starting materials (plant inputs) to Licensed Producers (“LP) of cannabis. 

As Canadian producers continue to scale up their production to meet market demand, the industry is faced with the challenges of industrial agriculture, including exposure to disease and contamination, batch to batch product inconsistency, and increased operational costs from inefficient use of space.  

Steadystem is a trusted partner committed to offering a solution to meet these major challenges through a specialized kind of plant cloning known as tissue culture, or micropropagation. 

CannTx will be previewing the Steadystem brand, as well as the Company’s medicinal and recreational brands at O’Cannabiz conference in Toronto, April 25-27 at the International Centre. Additional information for all three brands will be available via the Company website shortly.   

In addition, CannTx is delighted to announce that Steadystem has entered into its first contract for micropropagation services through a supply agreement with an Ontario-based Licensed Producer that has obtained its License to Sell under the Cannabis Act.  

“We are thrilled to launch our B2B brand and to enter into our first supply agreement,” said Mike Abbott, President and Co-Founder.We very much look forward to continuing our work in delivering on our business plan, and to adding significant value to current and emerging Licensed Producers through our micropropagation services division.”  


For further information, please contact: 

Jennifer Charlebois, Communications Manager 



About CannTx Life Sciences Inc. 

Founded in 2013, CannTx is a privately-owned CTLS-licensed Cannabis company, located in the heart of Canadian agricultural innovation. CannTx is focused on producing premium floral product for the medicinal and recreational markets and is uniquely equipped to become a commercial scale producer of micropropagated inputs for sale to licensed producers, as well as for use in its own state-of-the-art indoor facility. The CannTx solution involves harnessing biotechnology (specifically micropropagation and vertical farming) for Cannabis cultivation, which results in improved consistency of product, enhanced safety, greater selection, better availability and the agility to respond to changing consumer preferences.  

Forward-Looking Statements 

This press release contains statements that constitute “forward-looking information” (collectively, “forward-looking statements”) within the meaning of the applicable Canadian securities legislation. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. Any statement that discusses predictions, expectations, beliefs, plans, projections, objectives, assumptions, future events or performance (often but not always using phrases such as “expects”, or “does not expect”, “is expected”, “anticipates” or “does not anticipate”, “plans”, “budget”, “scheduled”, “forecasts”, “estimates”, “believes” or “intends” or variations of such words and phrases or stating that certain actions, events or results “may” or “could”, “would”, “might” or “will” be taken to occur or be achieved) are not statements of historical fact and may be forward-looking statements.  Forward-looking statements contained in this news release include, without limitation, statements regarding: the Company’s facility, expected capacity, production, business and operations. Although the Corporation believes that the expectations reflected in forward-looking statements are reasonable, it can give no assurance that the expectations of any forward-looking statements will prove to be correct. Known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Accordingly, readers should not place undue reliance on the forward-looking statements and information contained in this press release. Except as required by law, the Corporation disclaims any intention and assumes no obligation to update or revise any forward-looking statements to reflect actual results, whether as a result of new information, future events, changes in assumptions, changes in factors affecting such forward-looking statements or otherwise.